YOKNEAM ILIT, Israel, Nov. 27, 2024 /PRNewswire/ -- PixCell Medical, a leading innovator in point-of-care diagnostics, proudly announces that its groundbreaking HemoScreen CBC analyzer has achieved ...
Ozelle will present its AI-assisted hematology analyzer at MEDICA 2026, offering CBC, 7-part WBC differentials, and digital ...
The opportunity presented in fingerprick blood testing is one that many companies are chasing. Among these is Israeli diagnostics firm Sight Diagnostics, which announced Wednesday that the Food and ...
TEL AVIV, Israel--(BUSINESS WIRE)--Sight Diagnostics Ⓡ, the company behind the first FDA-cleared direct-from-fingerstick Complete Blood Count (CBC) analyzer, announced today it has raised $71 million ...
– Sight Diagnostics, the company behind the first FDA-approved fingerstick Complete Blood Count analyzer, announced it has raised $71 million in Series D funding from leading strategic investors ...
Sight Diagnostics, an Israeli medical devices startup that’s using computer vision and machine learning technology to speed up blood testing, is launching a point-of-care blood diagnostics system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results